# Horizon Therapeutics USA Inc. Horizon Therapeutics USA Inc. 2021 Term Loan B

Horizon Therapeutics USA Inc. Horizon Therapeutics USA Inc. 2021 Term Loan B is a security (CUSIP 44055UAD7) tracked across SEC portfolio filings. 2 registered fund positions totaling $735K via N-PORT as of 2022-12-30.

## Summary

- Issuer: Horizon Therapeutics USA Inc.
- Class: Horizon Therapeutics USA Inc. 2021 Term Loan B
- CUSIP: 44055UAD7
- Asset category: LON
- 13F holders: 0
- N-PORT fund positions: 2
- N-PORT value: $735K
- N-PORT report: 2022-12-30

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| [AIG Senior Floating Rate Fund](https://search.stillhousedata.com/fund/S000012952) | SUNAMERICA SENIOR FLOATING RATE FUND INC | $611K | 44.13% |
| [Delaware Strategic Allocation Fund](https://search.stillhousedata.com/fund/S000004196) | Delaware Group Foundation Funds | $123K | 6.93% |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/44055UAD7.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.